Impact of Eligibility Length on Prevalence Estimates Using Automated Healthcare Claims Data

被引：0
|
作者：
Zhu, Yanmin [1 ]
Liu, Wei [1 ]
Li, Yan [1 ]
Winterstein, Almut G. [1 ]
机构：
[1] Univ Florida, Pharmaceut Outcomes & Policy, Gainesville, FL USA
来源：
PHARMACOEPIDEMIOLOGY AND DRUG SAFETY | 2015年 / 24卷
关键词：
D O I：
暂无
中图分类号：
R1 [预防医学、卫生学];
学科分类号：
1004 ; 120402 ;
摘要：
1023
引用
收藏
页码：583 / 583
页数：1
相关论文
共 50 条
  • [1] Impact of minimum enrollment period requirements on disease prevalence estimates derived from claims data
    Murdock, Dana J.
    Jalbert, Jessica J.
    Ge, Wenzhen
    Sanchez, Robert
    Wu, Ning
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2023, 32 : 246 - 246
  • [2] Prevalence of Corneal Dystrophies in the United States: Estimates from Claims Data
    Moller, Hans Ulrik
    Sunde, Lone
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2013, 54 (01) : 387 - 387
  • [3] Enrollment factors and bias of disease prevalence estimates in administrative claims data
    Jensen, Elizabeth T.
    Cook, Suzanne F.
    Allen, Jeffery K.
    Logie, John
    Brookhart, Maurice Alan
    Kappelman, Michael D.
    Dellon, Evan S.
    ANNALS OF EPIDEMIOLOGY, 2015, 25 (07) : 519 - 525
  • [4] Prevalence of Corneal Dystrophies in the United States: Estimates from Claims Data
    Musch, David C.
    Niziol, Leslie M.
    Stein, Joshua D.
    Kamyar, Roheena M.
    Sugar, Alan
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2011, 52 (09) : 6959 - 6963
  • [5] Comparing prevalence estimates from US claims data by two methods
    Zito, Julie M.
    Korelitz, James J.
    Valluri, Satish
    Gardner, James F.
    Bethel, James
    Mattison, Donald R.
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2007, 16 : S120 - S120
  • [6] Misclassification in Administrative Claims Data: Quantifying the Impact on Treatment Effect Estimates
    Michele Jonsson Funk
    Suzanne N. Landi
    Current Epidemiology Reports, 2014, 1 (4) : 175 - 185
  • [7] Estimates of Toxoplasmosis Incidence Based on Healthcare Claims Data, Germany, 2011-2016
    Krings, Amrei
    Jacob, Josephine
    Seeber, Frank
    Pleyer, Uwe
    Walker, Jochen
    Stark, Klaus
    Wilking, Hendrik
    EMERGING INFECTIOUS DISEASES, 2021, 27 (08) : 2097 - 2106
  • [8] THE EFFECT OF LENGTH OF OBSERVATION AND CLAIMS DATA TYPE ON ESTIMATES OF COMORBIDITIES AMONG MEDICAID BENEFICIARIES
    Banahan, I. I. I. B. F.
    Pace, P. F.
    VALUE IN HEALTH, 2010, 13 (03) : A15 - A15
  • [9] Using healthcare claims data for outcomes research and pharmacoeconomic analyses
    Birnbaum, HG
    Cremieux, PY
    Greenberg, PE
    LeLorier, J
    Ostrander, J
    Venditti, L
    PHARMACOECONOMICS, 1999, 16 (01) : 1 - 8
  • [10] Feature engineering to detect fraud using healthcare claims data
    Kumaraswamy, Nishamathi
    Markey, Mia K.
    Barner, Jamie C.
    Rascati, Karen
    EXPERT SYSTEMS WITH APPLICATIONS, 2022, 210
12345